US 7253187
Heterocyclic inhibitors of ERK2 and uses thereof
granted A61PA61P1/16A61P11/00
Quick answer
US patent 7253187 (Heterocyclic inhibitors of ERK2 and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P17/06, A61P19/00